Impact of Blood Detection Capsule "HemoPill Acute ®" on the Time to Emergency Endoscopy in Case of Suspected Nonvariceal Upper Gastrointestinal Bleeding

  • STATUS
    Recruiting
  • End date
    Dec 18, 2024
  • participants needed
    72
  • sponsor
    Wuerzburg University Hospital
Updated on 18 September 2022

Summary

The study examines, whether the use of the HemoPill Acute ® capsule in case of suspected nonvariceal upper gastrointestinal bleeding can identify cases in which endoscopy can be delayed to 48-96 hours without risk to the patient.

Description

Despite a variety of scoring systems (Glasgow-Blatchford-Score, etc.) timing of endoscopy in case of suspecting nonvariceal bleeding in the upper gastrointestinal tract is still challenging.

While very early endoscopy (within 12 hours) is required in some cases, European Society of Gastrointestinal Endoscopy (ESGE) - guidelines recommend performing emergency endoscopy within 24 hours in other cases. However, a recent study (Siau et al. 2019) showed that even this time window is only kept in 59% of cases. Therefore this study examines, whether the use of the HemoPill Acute ® capsule in case of suspected nonvariceal upper gastrointestinal bleeding, can identify cases in which endoscopy can be delayed to 48-96 hours without risk to the patient.

In this study, after the routine administration of a proton pump inhibitor, hemodynamically stable emergency patients suspected of having non-variceal bleeding in the upper gastrointestinal tract receive a novel blood detection capsule (HemoPill Acute ®) for swallowing, whose result is available after 2 hours.

In case of blood detection in the upper gi-tract (capsule positive), the endoscopy will be performed within 12 hours.

If no blood is found in the upper GI tract (capsule negative), endoscopy will be performed after 48 to 96 hours, with the patient being monitored in hospital until then. In these cases, if clinical bleeding occurs before the planned endoscopy, the patient will receive an unscheduled emergency endoscopy.

Further treatment is carried out according to current clinical standards. 30 days after discharge, the patients will be asked by telephone about their further clinical course and possible complications.

This study is supported by Ovesco Endoscopy AG by making the capsule available free of Charge. The study is planned to recruit 72 participants over 48 months in several centers. If this procedure is found to be safe, the HemoPill Acute ® capsule can be used to reduce the number of emergency endoscopies.

Details
Condition Upper Gastrointestinal Bleeding
Treatment HemoPill Acute ®
Clinical Study IdentifierNCT04472364
SponsorWuerzburg University Hospital
Last Modified on18 September 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Emergency presentation with clinical suspicion of non-variceal upper GI bleeding (e.g. haematin vomiting, melena, etc.)
hemodynamic stable patient (heart rate <100 / min, Blood pressure sys ≥ 100mmHg)
Emergency endoscopy indicated (modified Glasgow-Blatchford-Score ≥ 2 points)
Administration of proton pump inhibitors possible (no allergy known)
Good communication (without translator) with the study doctor and fulfill all requirements of the study
Written consent after detailed information about the study

Exclusion Criteria

Hemodynamically unstable patients (HF> 100 / min, RR <100mmHg despite fluid administration) with indication for endoscopy within 12 hours
Indication for endoscopy within 12 hours recommended by endoscopy call service
Clinical suspicion of variceal bleeding of the upper GI tract (risk factors according to german guidelines: cirrhosis of the liver, splanchnic thrombosis, thrombocytopenia, known increased liver / spleen stiffness, known esophageal varices)
Clinical suspicion of lower GI bleeding (e.g. hematochezia)
Vomiting blood (hematemesis observed by the emergency doctor or in the clinic)
Patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis)
Severe acute and chronic organ diseases that need treatment (e.g. kidney replacement treatment) (ASA ≥4)
Changed anatomy of the upper GI tract (e.g. gastric resection)
Known or suspected gastrointestinal obstructions, strictures, fistulas or known diverticula
Dysphagia or other swallowing disorders
Awareness restrictions that make it impossible to swallow the HemoPill Acute ® capsule on your own
Patients with pacemakers, defibrillators, or other implantable electromedical devices
Known allergy to parylene (capsule surface)
Soon MRI scan planned
Pregnancy or breastfeeding
Mental impairment that limits the ability to meet all study requirements
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note